Skip to main content

Medpace Holdings, Inc.

MEDP
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001668397

In the last 90 days, Medpace Holdings, Inc. insiders filed 0 open-market purchases and 18 sales; 699 institutions reported holding it in 13F filings for Q2 2026, worth $13.1B in total; superinvestors Giverny Capital and Fundsmith hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Medpace Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
18 filings
7 insiders, $176.6M in total
Insiders trading
7
Net value
−$176.6M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Medpace Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Medpace Holdings, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Troendle August J.President & CEO389,456Sep 25, 202620
Burwig Susan EExec. VP, Operations65,984Sep 17, 202611
Kraft Robert O.Director955Aug 28, 20268
Brady Kevin M.CFO & Treasurer12,830Aug 24, 20263
Carley Brian TDirector27,825Aug 21, 20268
Davenport Fred B JrDirector3,798Aug 21, 20263
McCarthy Cornelius P. IIIDirector12,275Aug 13, 20268
Ewald Stephen PGeneral Counsel & Corp. Secy.20,343Jun 1, 20264
Gwadry-Sridhar Femida H.Director–May 18, 20261
Zander Dani S.Director–May 18, 20261
Geiger Jesse JPresident15,000Mar 19, 20263
Keating Ashley M.Director250May 21, 20240
Medpace Investors, LLC10% Owner4,733,019Mar 8, 20240
King Tom CDirector598May 24, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 2, 2023 (view filing)Jul 312 daysBrady Kevin M.CFO & TreasurerSSale−7.00K$255.00−$1.78M−53.8%6.00K after
Jul 31, 2023 (view filing)Jul 274 daysEwald Stephen PGeneral Counsel & Corp. Secy.SSale−21.9K$254.39−$5.56M−59.5%14.9K after
Jun 12, 2023 (view filing)Jun 84 daysTroendle August J.CEOSSale−49.3K$220.85−$10.9M−0.8%6.23M after10b5-1Duplicate filing
Jun 12, 2023 (view filing)Jun 84 daysMedpace Investors, LLC10% OwnerSSale−49.3K$220.85−$10.9M−0.8%6.23M after10b5-1
Jun 8, 2023 (view filing)Jun 6-72 daysTroendle August J.CEOSSale−169.0K$222.15−$37.5M−2.6%6.28M after2 lots10b5-1Duplicate filing
Jun 8, 2023 (view filing)Jun 6-72 daysMedpace Investors, LLC10% OwnerSSale−169.0K$222.15−$37.5M−2.6%6.28M after2 lots10b5-1
Apr 27, 2023 (view filing)Apr 252 daysTroendle August J.CEOSSale−31.6K$221.83−$7.02M−0.5%6.45M after10b5-1Duplicate filing
Apr 27, 2023 (view filing)Apr 252 daysMedpace Investors, LLC10% OwnerSSale−31.6K$221.83−$7.02M−0.5%6.45M after10b5-1
Nov 17, 2022 (view filing)Nov 15-162 daysBrady Kevin M.CFO & TreasurerSSale−2.00K$228.92−$457.8K−40.0%3.00K after2 lots
Nov 17, 2022 (view filing)Nov 152 daysGeiger Jesse JPresidentSSale−7.00K$230.00−$1.61M−52.3%6.38K after
Nov 3, 2022 (view filing)Nov 12 daysKraft Robert O.DirectorSSale−9.63K$221.42−$2.13M−100.0%0 after
Oct 31, 2022 (view filing)Oct 274 daysEwald Stephen PGeneral Counsel & Corp. Secy.SSale−6.50K$220.53−$1.43M−30.4%14.9K after
Sep 23, 2022 (view filing)Sep 221 dayMedpace Investors, LLC10% OwnerPPurchase+57.4K$154.59+$8.88M+0.9%6.48M afterDuplicate filing
Sep 23, 2022 (view filing)Sep 221 dayTroendle August J.CEOPPurchase+57.4K$154.59+$8.88M+0.9%6.48M after
Sep 22, 2022 (view filing)Sep 20-212 daysTroendle August J.CEOPPurchase+188.2K$158.39+$29.8M+3.0%6.43M after2 lotsDuplicate filing
Sep 22, 2022 (view filing)Sep 20-212 daysMedpace Investors, LLC10% OwnerPPurchase+188.2K$158.39+$29.8M+3.0%6.43M after2 lots
Sep 20, 2022 (view filing)Sep 16-194 daysMedpace Investors, LLC10% OwnerPPurchase+156.6K$151.92+$23.8M+2.6%6.24M after2 lotsDuplicate filing
Sep 20, 2022 (view filing)Sep 16-194 daysTroendle August J.CEOPPurchase+156.6K$151.92+$23.8M+2.6%6.24M after2 lots
Sep 16, 2022 (view filing)Sep 14-152 daysTroendle August J.CEOPPurchase+125.0K$152.89+$19.1M+2.1%6.08M after2 lotsDuplicate filing
Sep 16, 2022 (view filing)Sep 14-152 daysMedpace Investors, LLC10% OwnerPPurchase+125.0K$152.89+$19.1M+2.1%6.08M after2 lots
Sep 14, 2022 (view filing)Sep 12-132 daysTroendle August J.CEOPPurchase+125.0K$162.35+$20.3M+2.1%5.96M after2 lotsDuplicate filing
Sep 14, 2022 (view filing)Sep 12-132 daysMedpace Investors, LLC10% OwnerPPurchase+125.0K$162.35+$20.3M+2.1%5.96M after2 lots
Sep 12, 2022 (view filing)Sep 8-94 daysTroendle August J.CEOPPurchase+113.1K$160.99+$18.2M+2.0%5.83M after2 lotsDuplicate filing
Sep 12, 2022 (view filing)Sep 8-94 daysMedpace Investors, LLC10% OwnerPPurchase+113.1K$160.99+$18.2M+2.0%5.83M after2 lots
Sep 8, 2022 (view filing)Sep 6-72 daysMedpace Investors, LLC10% OwnerPPurchase+113.1K$149.16+$16.9M+2.0%5.72M after2 lotsDuplicate filing
Sep 8, 2022 (view filing)Sep 6-72 daysTroendle August J.CEOPPurchase+113.1K$149.16+$16.9M+2.0%5.72M after2 lots
Sep 6, 2022 (view filing)Sep 1-25 daysMedpace Investors, LLC10% OwnerPPurchase+90.8K$144.77+$13.1M+1.6%5.60M after2 lotsDuplicate filing
Sep 6, 2022 (view filing)Sep 1-25 daysTroendle August J.CEOPPurchase+90.8K$144.77+$13.1M+1.6%5.60M after2 lots
Jul 20, 2022 (view filing)Jul 182 daysTroendle August J.CEOPPurchase+8.33K$145.00+$1.21M+0.2%5.51M afterDuplicate filing
Jul 20, 2022 (view filing)Jul 182 daysMedpace Investors, LLC10% OwnerPPurchase+8.33K$145.00+$1.21M+0.2%5.51M after
Jul 18, 2022 (view filing)Jul 144 daysTroendle August J.CEOPPurchase+22.3K$144.59+$3.22M+0.4%5.51M afterDuplicate filing
Jul 18, 2022 (view filing)Jul 144 daysMedpace Investors, LLC10% OwnerPPurchase+22.3K$144.59+$3.22M+0.4%5.51M after
Feb 22, 2022 (view filing)Feb 175 daysDavenport Fred B JrDirectorPPurchase+500$145.80+$72.9K+33.3%2.00K after
Jan 6, 2022 (view filing)Jan 42 daysTroendle August J.CEOSSale−3.34K$213.44−$712.5K−0.1%5.48M afterDuplicate filing
Jan 6, 2022 (view filing)Jan 42 daysMedpace Investors, LLC10% OwnerSSale−3.34K$213.44−$712.5K−0.1%5.48M after
Jan 4, 2022 (view filing)Dec 30, 2021-Jan 3, 20225 daysTroendle August J.CEOSSale−50.2K$217.02−$10.9M−0.9%5.49M after3 lotsDuplicate filing
Jan 4, 2022 (view filing)Dec 30, 2021-Jan 3, 20225 daysMedpace Investors, LLC10% OwnerSSale−50.2K$217.02−$10.9M−0.9%5.49M after3 lots
Dec 30, 2021 (view filing)Dec 28-292 daysTroendle August J.CEOSSale−40.9K$221.35−$9.05M−0.7%5.54M after2 lotsDuplicate filing
Dec 30, 2021 (view filing)Dec 28-292 daysMedpace Investors, LLC10% OwnerSSale−40.9K$221.35−$9.05M−0.7%5.54M after2 lots
Dec 28, 2021 (view filing)4:16 PM ETDec 23-275 daysMedpace Investors, LLC10% OwnerSSale−62.0K$225.03−$14.0M−1.1%5.58M after2 lotsDuplicate filing
Dec 28, 2021 (view filing)Dec 23-275 daysTroendle August J.CEOSSale−62.0K$225.03−$14.0M−1.1%5.58M after2 lots
Dec 23, 2021 (view filing)Dec 21-222 daysTroendle August J.CEOSSale−57.1K$218.81−$12.5M−1.0%5.64M after2 lotsDuplicate filing
Dec 23, 2021 (view filing)Dec 21-222 daysMedpace Investors, LLC10% OwnerSSale−57.1K$218.81−$12.5M−1.0%5.64M after2 lots
Dec 21, 2021 (view filing)Dec 17-204 daysTroendle August J.CEOSSale−53.3K$213.16−$11.4M−0.9%5.70M after2 lotsDuplicate filing
Dec 21, 2021 (view filing)Dec 17-204 daysMedpace Investors, LLC10% OwnerSSale−53.3K$213.16−$11.4M−0.9%5.70M after2 lots
Dec 17, 2021 (view filing)Dec 15-162 daysTroendle August J.CEOSSale−8.38K$210.24−$1.76M−0.1%5.75M after2 lotsDuplicate filing
Dec 17, 2021 (view filing)Dec 15-162 daysMedpace Investors, LLC10% OwnerSSale−8.38K$210.24−$1.76M−0.1%5.75M after2 lots
Dec 13, 2021 (view filing)Dec 9-104 daysTroendle August J.CEOSSale−15.3K$212.09−$3.25M−0.3%5.76M after2 lotsDuplicate filing
Dec 13, 2021 (view filing)Dec 9-104 daysMedpace Investors, LLC10% OwnerSSale−15.3K$212.09−$3.25M−0.3%5.76M after2 lots
Dec 9, 2021 (view filing)Dec 7-82 daysTroendle August J.CEOSSale−34.4K$212.29−$7.30M−0.6%5.77M after2 lotsDuplicate filing